DNM3 Antibody

What is DNM3 and why is it significant for research applications?

DNM3 (Dynamin 3) is a member of the dynamin family of mechanochemical enzymes (including DNM1, DNM2, and DNM3) that participate in membrane dynamics by hydrolyzing nucleotides to link cellular membranes to the actin cytoskeleton . The human DNM3 protein has an expected molecular weight of 97.7 kDa and exists in five reported isoforms . DNM3 may also be known by alternative names including Dyna III, T-dynamin, and dynamin family member .

Research significance:

• Functions as a tumor suppressor in non-small-cell lung cancer (NSCLC)

• Participates in megakaryocyte growth and development

• Interacts with key signaling molecules including growth factor receptor-bound protein 2 (GRB2)

DNM3 antibodies enable researchers to investigate protein expression, localization, and interactions across various experimental contexts. Understanding DNM3 biology has significant implications for cancer research, hematology, and cellular biology.

What are the optimal experimental conditions for using DNM3 antibodies in different applications?

When using DNM3 antibodies, researchers should consider the following application-specific recommendations:

Western Blot:

• Recommended dilution range: 1/500 - 1/2000

• Protein detection: Expected band at approximately 97 kDa

• Sample preparation: Standard cell/tissue lysis procedures are suitable

• Storage: Aliquot and store at -20°C to avoid repeated freeze/thaw cycles

Immunohistochemistry (IHC):

• Recommended dilution range: 1/20 - 1/200

• Fixation: Standard formalin fixation and paraffin embedding procedures

• Antigen retrieval: May be necessary depending on fixation method

• Reported successful dilution: 1:250 for rabbit polyclonal DNM3 antibody

Immunoprecipitation (IP):

• Recommended dilution range: 1/200 - 1/1000

• Buffer composition: PBS, pH 7.3, with 0.02% sodium azide and 50% glycerol

• Antibody concentration: Typically 2 mg/ml

Flow Cytometry and Immunofluorescence:

• Dilution must be optimized for specific antibody and application

• Fixation and permeabilization protocols should be optimized

For all applications, researchers should include appropriate positive and negative controls to validate antibody specificity and performance.

How can DNM3 antibodies be used to investigate its role in cancer biology?

Research has established DNM3 as a tumor suppressor in non-small-cell lung cancer through several key mechanisms :

Expression Analysis in Cancer:

Functional Studies:

• Knockdown of DNM3 using shRNA significantly promotes lung cancer cell proliferation and migration

• BrdU assays confirm enhanced proliferation following DNM3 depletion

• Transwell migration assays demonstrate increased migration in cells with reduced DNM3

• Overexpression of DNM3 suppresses H1299 and A549 cell proliferation

Mechanistic Investigation:

• DNM3 interacts with growth factor receptor-bound protein 2 (GRB2)

• This interaction disrupts the formation of the c-MET-GRB2-STAT3 complex

• DNM3 depletion enhances STAT3 activation, regulating genes related to proliferation and metastasis

• The c-MET inhibitor crizotinib effectively suppresses tumor growth and metastasis in cells with low DNM3 expression

Researchers can employ DNM3 antibodies to:

• Assess DNM3 expression levels in patient samples for prognostic evaluation

• Study protein-protein interactions through co-immunoprecipitation

• Investigate subcellular localization changes during cancer progression

• Monitor treatment responses to targeted therapies like c-MET inhibitors

What experimental approaches are recommended for studying DNM3's role in megakaryocyte development?

DNM3 has been identified as a participant in megakaryocyte development and platelet formation . Researchers investigating this function should consider these approaches:

Expression Analysis During Differentiation:

• DNM3 shows significant upregulation during megakaryocytopoiesis with:

  • 8.2±2.1-fold increase identified by microarray analysis

  • 20.7±3.4-fold increase confirmed by real-time qRT-PCR

Subcellular Localization:

• Confocal microscopy reveals diffuse cytoplasmic distribution with punctate appearance in pro-platelet processes

• Immunogold electron microscopy shows wide distribution in the cytoplasm without specific organelle localization

Functional Studies:

• Overexpression in umbilical cord blood CD34+ cells results in:

  • Increased total nucleated cells

  • Amplified colony forming cells (CFCs)

  • Enhanced colony forming unit-megakaryocytes (CFU-MKs)

  • Increased expression of NFE-2 and β1 tubulin

Recommended Methodological Approaches:

• Expression Studies:

  • Western blot with validated DNM3 antibodies (typically at 1:250 dilution)

  • qRT-PCR for transcript analysis during differentiation stages

  • Flow cytometry for population-based analysis

• Imaging Techniques:

  • Confocal microscopy with appropriate fluorophore-conjugated secondary antibodies

  • Immunogold labeling for ultrastructural localization

  • Live-cell imaging for dynamic processes

• Functional Analysis:

  • Lentiviral transduction for overexpression or knockdown studies

  • Colony formation assays to assess megakaryocyte progenitor activity

  • Analysis of differentiation markers (CD41, CD61, NFE-2, β1-tubulin)

How can researchers address contradictory findings when studying DNM3 across different experimental systems?

When encountering contradictory results in DNM3 research, consider these methodological approaches:

1. Context-Dependent Function Analysis:

• DNM3 functions as a tumor suppressor in lung cancer but promotes growth in megakaryocyte development

• Design experiments to directly compare DNM3's role across different cell types using identical methodologies

• Create a comparative analysis framework addressing:

  • Cell type-specific binding partners

  • Expression levels of DNM3 isoforms

  • Post-translational modifications

  • Subcellular localization patterns

2. Isoform-Specific Investigation:

• DNM3 exists in 5 reported isoforms

• Use isoform-specific antibodies or genetic approaches

• Determine the expression profile of each isoform in your experimental system

• Consider creating an isoform expression table comparing different tissues/cell types

3. Technical Approach Standardization:

• Validate antibody specificity in each experimental system

• Use identical protocols for protein extraction and analysis

• Include multiple positive and negative controls

• Employ complementary techniques (Western blot, qPCR, immunofluorescence)

4. Mechanistic Resolution Strategies:

• Conduct detailed pathway analysis in different systems

• Identify key interaction partners through co-immunoprecipitation followed by mass spectrometry

• Use genetic approaches (CRISPR/Cas9, shRNA) to validate functional relationships

• Design rescue experiments to confirm specificity of observed phenotypes

5. Comprehensive Literature Analysis:

• Create a systematic review of published DNM3 findings

• Identify methodological differences that might explain contradictions

• Contact authors of conflicting studies to discuss technical details

• Consider collaborative efforts to resolve contradictions

What are the most effective validation strategies for DNM3 antibodies?

Thorough validation is critical for ensuring reliable and reproducible results with DNM3 antibodies:

1. Specificity Validation:

• Genetic Approaches:

  • siRNA/shRNA knockdown followed by Western blot

  • CRISPR/Cas9 knockout validation

  • Overexpression of DNM3 as a positive control

• Biochemical Validation:

  • Peptide competition assays

  • Testing against recombinant DNM3 protein

  • Cross-reactivity testing against related proteins (DNM1, DNM2)

2. Application-Specific Validation:

3. Troubleshooting Common Issues:

• Multiple Bands in Western Blot:

  • May represent isoforms (DNM3 has 5 reported variants)

  • Could indicate degradation products

  • Try fresh sample preparation and protease inhibitors

• Weak or No Signal:

  • Optimize antibody concentration

  • Extend incubation time

  • Enhance signal with amplification systems

  • Check sample preparation and protein integrity

• High Background:

  • Increase blocking time/concentration

  • Add additional washing steps

  • Reduce antibody concentration

  • Try alternative blocking agents

How can DNM3 antibodies be utilized to explore potential therapeutic applications?

Emerging research suggests several promising therapeutic applications where DNM3 antibodies serve as critical research tools:

1. Targeted Cancer Therapies:

• c-MET inhibitors like crizotinib effectively suppress tumor growth in cells with low DNM3 expression

• DNM3 antibodies can help:

  • Identify patients likely to respond to c-MET inhibitors

  • Monitor treatment efficacy through changes in DNM3-related signaling

  • Discover new therapeutic targets within the DNM3-regulated pathways

2. Biomarker Development:

• Lower DNM3 expression correlates with poor survival in lung cancer patients

• Research applications include:

  • Prognostic stratification of cancer patients

  • Predictive biomarker development for treatment selection

  • Monitoring disease progression through DNM3 expression changes

3. Pathway-Targeted Interventions:

• DNM3 interrupts the c-MET-GRB2-STAT3 signaling axis

• Investigation opportunities include:

  • High-throughput screening for compounds that modulate DNM3 expression

  • Development of peptide mimetics that replicate DNM3's interaction with GRB2

  • Combination therapies targeting multiple nodes in the pathway

4. Hematological Applications:

• DNM3 overexpression enhances megakaryocyte development and platelet formation

• Potential applications include:

  • Development of interventions for thrombocytopenia

  • Improved methods for in vitro platelet production

  • Novel treatments for megakaryocyte-related disorders

5. Methodological Research Focus:

• Develop DNM3 isoform-specific antibodies for precise targeting

• Create phospho-specific antibodies to monitor activation states

• Establish standardized protocols for patient sample analysis

What are the key considerations when designing experiments to investigate DNM3's role in signal transduction?

When investigating DNM3's role in signaling pathways, researchers should consider these experimental design elements:

1. Pathway-Specific Experimental Design:

• DNM3 interacts with GRB2, affecting the c-MET-GRB2-STAT3 signaling axis

• Key experimental approaches:

  • Co-immunoprecipitation with DNM3 antibodies to identify interaction partners

  • Proximity ligation assays to visualize protein interactions in situ

  • Phosphorylation analysis of downstream effectors (particularly STAT3)

  • Reporter assays for STAT3-dependent transcription

2. Temporal Dynamics Consideration:

• Signal transduction events occur with specific timing

• Recommended approaches:

  • Time-course experiments following stimulation (e.g., with growth factors)

  • Synchronized cell populations for consistent signaling responses

  • Live-cell imaging with fluorescently tagged proteins

  • Rapid lysis techniques to capture transient interactions

3. Spatial Organization Analysis:

• DNM3 shows specific subcellular distribution patterns

• Analytical methods:

  • High-resolution confocal microscopy

  • Subcellular fractionation followed by Western blotting

  • FRET/BRET analysis for protein proximity detection

  • Super-resolution microscopy for detailed localization studies

4. Genetic Manipulation Strategies:

• Create controlled systems to study DNM3 function

• Approaches include:

  • CRISPR/Cas9 knockout followed by rescue with wild-type or mutant DNM3

  • Inducible expression systems for temporal control

  • Domain mapping through truncation mutants

  • Site-directed mutagenesis of key functional residues

5. Comprehensive Readout Systems:

• Monitor multiple aspects of signaling simultaneously

• Methods include:

  • Multiplex analysis of phosphorylation events

  • Transcriptional profiling following DNM3 manipulation

  • Proteomics approaches to identify global changes

  • Functional assays relevant to the biological context (proliferation, migration, differentiation)

By applying these methodological approaches, researchers can build a comprehensive understanding of DNM3's complex roles in cellular signaling and disease processes, potentially leading to new therapeutic strategies.